Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-03

FDA Approved: PAROXETINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

ANI Pharmaceuticals received FDA approval for an original ANDA application for paroxetine, a generic antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)

Snippet

ORIG AP for PAROXETINE (PAROXETINE)